Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;16(4):1157-1166.
doi: 10.1007/s12105-022-01484-z. Epub 2022 Aug 10.

Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution

Miguel Rito  1   2 , Susana Esteves  3 , Isabel Fonseca  4   5
Affiliations

Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution

Miguel Rito et al. Head Neck Pathol. 2022 Dec.

Abstract

Background: Basal cell adenoma (BCA) and adenocarcinoma (BCAd) are two of the least frequent salivary gland tumors. We describe the largest series of these neoplasms, spanning over a period of 50 years (1970-2020), diagnosed and treated in a single Institution.

Methods: Sixty-eight cases were identified. Clinical and pathological data were collected and correlated with outcome.

Results: Forty-one BCA and 27 BCAd were identified. BCA cases had almost pristine prognosis, with only a relapse in a tumor inadequately excised. Ten patients with BCAd developed metastases, and 14 died from the disease. The 2-year and 5-year survival was of 76% and 42%.

Conclusions: The importance of adequate excision is reinforced in BCA, with no recurrences occurring when margins were negative. Contrary to previous reports, BCAd was not associated with a good prognosis. A better understanding of the genetics of these neoplasms may identify therapeutic options when dealing with inoperable or metastatic disease.

Keywords: Basal cell adenocarcinoma; Basal cell adenoma; Carcinoma ex pleomorphic adenoma; Head and neck neoplasms; Otorhinolaryngologic neoplasms; Salivary gland.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Hematoxylin and eosin images of three of the cases identified: A and B a basal cell adenoma, with the typical basaloid cytology and well-defined borders; C and D a basal cell adenocarcinoma, with an obvious infiltrative growth pattern, with nodules on desmoplastic stroma; and E and F a highly aggressive basal cell adenocarcinoma ex-pleomorphic adenoma with an invasive front that reached the dermis (E) and a residual hyalinized nodule of a pleomorphic adenoma within the tumor (F)
Graph 1
Graph 1
Survival probability along time (months) per primary location of the tumor (global p-value mentioned)
Graph 2
Graph 2
Survival probability along time (months) per surgery plus radiation vs surgery alone (global p-value mentioned)
Graph 3
Graph 3
Survival probability along time (months) per complete vs incomplete excision (global p-value mentioned)
See this image and copyright information in PMC

References

    1. WHO Classification of Head and Neck Tumours [Internet; beta version ahead of print] [Internet]. (2022) 5th ed. Lyon (France): International Agency for Research on Cancer. https://tumourclassification.iarc.who.int/chapters/52. Accessed 10 July 2022
    1. Muller S, Barnes L. Basal cell adenocarcinoma of the salivary glands: report of seven cases and review of the literature. Cancer Interdiscip Int J Am Cancer Soc. 1996;78:2471–2477. - PubMed
    1. Zhan KY, Lentsch EJ. Basal cell adenocarcinoma of the major salivary glands: a population-level study of 509 cases. Laryngoscope. 2016;126:1086–1090. doi: 10.1002/lary.25713. - DOI - PubMed
    1. Luna MA, Batsakis JG, El-Naggar AK. Basaloid monomorphic adenomas. Ann Otol Rhinol Laryngol. 1991;100:687–690. doi: 10.1177/000348949110000818. - DOI - PubMed
    1. Chen KT. Carcinoma arising in monomorphic adenoma of the salivary gland. Am J Otolaryngol. 1985;6:39–41. doi: 10.1016/S0196-0709(85)80007-7. - DOI - PubMed